CRA Financial Services »

Aclaris Therapeutics shares owned by CRA Financial Services

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by CRA Financial Services from 13F filings

Historical chart of CRA Financial Services investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by CRA Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by CRA Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $34k 18k 1.90
2025-06-30 $25k 18k 1.42

More positions owned by CRA Financial Services

Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Specialized Funds Div App Etf (VIG)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Index Fds Small Cp Etf (VB)
Spdr Series Trust S&p Divid Etf (SDY)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for CRA Financial Services

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
Vanguard Group
BlackRock
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Morgan Stanley
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
Renaissance Technologies
Palo Alto Investors
Millennium Management

View all funds holding Aclaris Therapeutics